Diabetes

Diabetes is a complex, chronic disease requires a multifaceted approach to management that combines education and support, lifestyle modifications, and pharmacological treatment.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Those who teach patients with diabetes about insulin must be aware of an unusual situation that can happen when using insulin pens with automatic needle retraction devices.

As we celebrate the good news that antiretroviral therapy (ART) has led to significantly longer life expectancies among individuals with HIV, we need to acknowledge the bad news that individuals with HIV are significantly more likely to develop age-related comorbidities at earlier ages.

Researchers are developing novel treatments to support weight management, although limited data supports their use in diabetes.

Weight can be a difficult topic for patients, as people with diabetes often have trouble losing weight and medications can cause weight gain.

Chemotherapy is difficult, and in children even more so. Sproutel has teamed up with Aflac to create a companion robot to help children undergo chemotherapy easier.

Greater risk of stillbirths, emergency Caesarean sections, and infant mortality found to be associated with both type 1 and type 2 diabetes.

Mice treated with a repurposed diabetes medication performed better on learning and memory tests.

According to a 2009 Harvard study, 62% of all bankruptcy was a direct result of medical debt.

Be proud of what you do every day.

More than one-third of metformin doses are not taken by patients with type 2 diabetes.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Immunotherapy may reverse type 1 diabetes.

Ertugliflozin (Steglatro) is also approved as part of 2 fixed-dose combinations.

Abbott has released its newest system for type 1 and 2 diabetes.

Now that Eli Lilly is looking to create a closed-loop system for diabetes management, does that mean this product will soon be available?

The cornerstone of working with patients is sharing decision-making and presenting information in a way that helps patients understand the risks and benefits of various choices.

HMG-CoA reductase inhibitors are a class of lipid-lowering medications. Here is a look at guidelines and studies for health care professionals.

Top articles of the week from The American Journal of Pharmacy Benefits.

Liver cancer is the most common cancer caused by diabetes and obesity.

Ademlog (insulin lispro injection) approved to control blood glucose levels among patients with diabetes.

Updated diabetes treatment guidelines address the use of the medications with potential cardiovascular benefit.